A few quotes from trent, on the ama show, reddit
Long,but enjoy the read. "There are few "insider information" type questions I can't legally respond to, but I will give my opinion on the Price/Sales ratio .. regardless of what you see as fair, we are currently trading at approximately 9.0x Net revenue to Enterprise Value (EV), with positive AEBITDA, 5 quarters of net revenue growth (including 94% YoY for Q2), ($8.1M) of cash used in operations for the past three quarters combined (not including non-cash working capital items), healthy margins relative to peers and SG&A that is decling as a % of net revenue (now among the best of the LPs). Now compare that to CGC at 31.3x, APHA at 12.9x, OGI at 17.1x, etc, etc. I believe we have plenty of room to move." "The Zenabis EU partner has an established pharmaceutical business and facilities that can be leveraged to deliver product to the EU market from Malta. Products destined for the EU market need to be processed in an EUGMP certified facility. The Malta facility has been EUGMP certified. EUGMP is a quality certification that allows us to sell in to the EU. Once the deal it complete HEXO will be able to leverage the EUGMP facility." "We are actually number #4 in market today in terms of Adult-use Canadian Recreational Sales, but #3 with Zenabis included (based on the most recently filed financial reports of the top LP's). At all our respective last quarters, we would only be $3M behind #2 for the quarter, and we have internal plans to at least try to overtake that position organically. That said, number one is held by the combination of Aphria and Tilray, and to their credit, it's a significant stagger to make up. Doing so may require more M&A, and while we wouldn't/couldn't disclose specific activity HEXO may be involved in at this time, or specific other companies that could be involved, we are on record as saying we're active." ""Hello Trent. The beverage revenue from 2nd quater were below expectation, where do you see the sales trend going foreword Hi Weedrobot ... Not sure what the expectation was, but our sales in Q2 were up 94% YoY. To put that in perspective, based on the most recently published financial results of the other top LP's, here's the information I have .... CGC +23%, OGI -23%, TLRY +19%, APHA +33%, ACB +23%, Cronos +83% and SNDL -6%. We had a great quarter, just my perspective. In terms of the future, we don't provide guidance, but we believe we're well positioned in the market"